Anakinra/canakinumabHypertransaminasaemia: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2014年 / 1517卷 / 1期

关键词：

D O I：

10.1007/s40278-014-3092-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：28 / 28

相关论文

共 50 条

[21] Anakinra/methylprednisolone/plasmaLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1956 (1) : 54 - 54
[22] Anakinra/tisagenlecleucel/tocilizumabVarious toxicities: 3 case reports
Reactions Weekly, 2022, 1912 (1) : 35 - 35
[23] Anakinra/canakinumabDRESS-syndrome: 2 case reports
Reactions Weekly, 2017, 1656 (1) : 44 - 44
[24] Anakinra/dexamethasone/prednisoloneVarious toxicities: 2 case reports
Reactions Weekly, 2020, 1820 (1) : 30 - 30
[25] Anakinra/canakinumabInflammatory bowel disease: 3 case reports
Reactions Weekly, 2017, 1653 (1) : 43 - 43
[26] Anakinra/ciclosporin/corticosteroidsLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1969 (1) : 34 - 34
[27] Anakinra/colchicineNo response and lack of efficacy: 7 case reports
Reactions Weekly, 2024, 2032 (1) : 41 - 41
[28] Anakinra/canakinumabAllergic reactions and disease progression: 3 case reports
Reactions Weekly, 2020, 1820 (1) : 29 - 29
[29] Anakinra/infliximabThrombocytopenia and infusion-related reaction: 2 case reports
Reactions Weekly, 2018, 1733 (1) : 45 - 45
[30] Anakinra/cotrimoxazole/immune-globulinLack of efficacy: 2 case reports
Reactions Weekly, 2022, 1927 (1) : 42 - 42

← 1 2 3 4 5 →